SCHEMBL690055

SCHEMBL690055

CN(c1cccc(N)c1)c1cc(Nc2ccccc2)ncn1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 6/20 0.53
TNNI3K Q59H18 3/20 0.53
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 1/20 0.44
LMNA P02545 2/20 0.43
KDM4E B2RXH2 1/20 0.43
GAA P10253 1/20 0.43
MAPT P10636 1/20 0.43
GFER P55789 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
CYP1A2 P05177 4/20 0.43
CYP2D6 P10635 3/20 0.43
CLK4 Q9HAZ1 3/20 0.42
CYP3A4 P08684 2/20 0.42
TSHR P16473 2/20 0.42
CYP2C19 P33261 2/20 0.42
ALDH1A1 P00352 1/20 0.42
MAPK1 P28482 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2778932 0.92 EGFR (0.53) EGFRTNNI3KMEN1KMT2ANPC1
SCHEMBL413659 0.88 TNNI3K (0.54) EGFRTNNI3KMEN1KMT2ANPC1
SCHEMBL4235274 0.85 THRB (0.57) EGFRTNNI3KMEN1KMT2AKDM4E
SCHEMBL4234991 0.83 THRB (0.54) EGFRTNNI3KMEN1KMT2AKDM4E
SCHEMBL11317380 0.77 MEN1 (0.55) EGFRTNNI3KMEN1KMT2ANPC1
SCHEMBL691596 0.77 MEN1 (0.67) EGFRTNNI3KMEN1KMT2ANPC1
SCHEMBL690595 0.77 EGFR (0.55) EGFRTNNI3KLMNAMAPTCYP1A2
SCHEMBL21109107 0.73 EGFR (0.43) EGFRMEN1KMT2ARAB9ALMNA
SCHEMBL690944 0.72 EGFR (0.61) EGFRTNNI3K
SCHEMBL17260963 0.72 KDR (0.51) CYP2D6CYP3A4CYP2C19CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2421538-A1 HETEROARYL COMPOUNDS AND USES THEREOF Avila Therapeutics, Inc. (US) 2012-02-29 EP disclosed
WO-2010123870-A1 HETEROARYL COMPOUNDS AND USES THEREOF AVILA THERAPEUTICS, INC. (US) 2010-10-28 WO disclosed